For millions of people living with diabetes, checking blood sugar remains a daily routine that often involves fingersticks or wearing a continuous glucose monitor (CGM) with a tiny sensor inserted beneath the skin. Although CGMs have dramatically improved diabetes management, many people still hope for a truly needle-free alternative. That …
Read More »The Diabetes Organ Nobody Talks About: Could Bone Hold the Next Treatment Breakthrough?
When most people think about diabetes, they picture the pancreas, insulin, or blood sugar. However, researchers are increasingly asking a different question: what if another organ has been quietly influencing glucose metabolism all along? Surprisingly, the answer may be the skeleton. For decades, bone was viewed primarily as the body’s …
Read More »Could Tiny Cellular Messengers Predict Diabetes Years Before It Develops?
Diabetes often develops silently for years before blood sugar levels become high enough for a diagnosis. What if tiny biological packages circulating in the bloodstream could reveal those hidden changes long before symptoms appear? Researchers are increasingly studying how exosomes may serve as biomarkers for diabetes because these microscopic messengers …
Read More »The Hidden Cost of Diabetes Care: Why Treatment Burden Is Becoming a Clinical Outcome
Managing diabetes has never offered more therapeutic options. Continuous glucose monitors (CGMs), automated insulin delivery systems, GLP-1 receptor agonists, SGLT2 inhibitors, and individualized treatment plans have transformed patient care. Yet despite these advances, many people with diabetes continue to struggle, not because treatments are ineffective, but because the overall workload …
Read More »Beyond Blood Sugar: Could Metabolomics Predict Diabetes Years Before Symptoms Appear?
Diabetes is often diagnosed only after blood sugar levels have already risen above normal. However, what if the earliest warning signs appeared years before glucose levels changed? That question is driving exciting research into metabolomics, a rapidly growing field that analyzes tiny molecules produced during normal metabolism. Instead of focusing …
Read More »The Return of C-Peptide: Why This Old Biomarker Is Finding New Clinical Uses
For many years, C-peptide testing was viewed as a simple tool to distinguish type 1 diabetes from type 2 diabetes. However, the story has changed. As researchers gain a better understanding of pancreatic beta-cell function, C-peptide testing in diabetes has become much more valuable than a diagnostic aid alone. Today, …
Read More »Why Blood Sugar Changes Every Month: Using CGM to Manage Luteal Phase Insulin Resistance
Many women with diabetes notice that blood sugar levels become harder to control during certain weeks of the month. Despite eating the same meals, taking the same insulin doses, and maintaining consistent activity levels, glucose readings may suddenly climb. This recurring pattern is often linked to luteal phase insulin resistance, …
Read More »Can Sound Waves Treat Diabetes? The Emerging Science of Hepatic Neuromodulation
For decades, diabetes treatment has centered on medications, insulin therapy, lifestyle changes, and increasingly sophisticated medical devices. But what if a completely different approach could help regulate blood sugar without adding another drug? That intriguing question is driving research into hepatic neuromodulation for diabetes, a promising field that uses focused …
Read More »The End of Sliding-Scale Insulin? How Predictive AI Is Transforming Inpatient Diabetes Care
Hospital glucose management has long relied on reactive treatment strategies, especially sliding-scale insulin protocols that respond to blood glucose after it has already risen. While this approach remains common, healthcare systems are increasingly exploring AI solutions for inpatient diabetes care that predict glucose changes before they become dangerous. Instead of …
Read More »Could “Smart” Insulin End Hypoglycemia? The Race Toward Glucose-Responsive Therapy
For more than a century, insulin has saved millions of lives. Yet despite remarkable advances in diabetes technology, one major challenge remains: preventing hypoglycemia while maintaining excellent glucose control. That is why researchers are developing glucose-responsive insulin, often called “smart” insulin. Instead of delivering a fixed amount of insulin regardless …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.